The regulation of appetite

被引:72
作者
Druce, M [1 ]
Bloom, SR [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll Med, Dept Metab Med, London W12 0NN, England
基金
英国惠康基金;
关键词
D O I
10.1136/adc.2005.073759
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The worsening global obesity epidemic, particularly the increase in childhood obesity, has prompted research into the mechanisms of appetite regulation. Complex pathways modulate energy balance, involving appetite centres in the hypothalamus and brain stem, and hormonal signals of energy status released by the gut and by the periphery. Better understanding of appetite regulation improves understanding of the aetiology of obesity. Manipulation of this homoeostatic system offers potentially useful treatments for obesity.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 61 条
[1]   DISTRIBUTION AND RELEASE OF HUMAN PANCREATIC POLYPEPTIDE [J].
ADRIAN, TE ;
BLOOM, SR ;
BRYANT, MG ;
POLAK, JM ;
HEITZ, P ;
BARNES, AJ .
GUT, 1976, 17 (12) :940-944
[2]   Role of leptin in the neuroendocrine response to fasting [J].
Ahima, RS ;
Prabakaran, D ;
Mantzoros, C ;
Qu, DQ ;
Lowell, B ;
MaratosFlier, E ;
Flier, JS .
NATURE, 1996, 382 (6588) :250-252
[3]   GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes [J].
Ahrén, B ;
Schmitz, O .
HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) :867-876
[4]   Characterization of the effects of pancreatic polypeptide in the regulation of energy balance [J].
Asakawa, A ;
Inui, A ;
Yuzuriha, H ;
Ueno, N ;
Katsuura, G ;
Fujimiya, M ;
Fujino, MA ;
Niijima, A ;
Meguid, MM ;
Kasuga, M .
GASTROENTEROLOGY, 2003, 124 (05) :1325-1336
[5]   INSULIN AND INSULIN-LIKE GROWTH-FACTORS IN THE CNS [J].
BASKIN, DG ;
WILCOX, BJ ;
FIGLEWICZ, DP ;
DORSA, DM .
TRENDS IN NEUROSCIENCES, 1988, 11 (03) :107-111
[6]   Gut hormone PYY3-36 physiologically inhibits food intake [J].
Batterham, RL ;
Cowley, MA ;
Small, CJ ;
Herzog, H ;
Cohen, MA ;
Dakin, CL ;
Wren, AM ;
Brynes, AE ;
Low, MJ ;
Ghatei, MA ;
Cone, RD ;
Bloom, SR .
NATURE, 2002, 418 (6898) :650-654
[7]   Inhibition of food intake in obese subjects by peptide YY3-36 [J].
Batterham, RL ;
Cohen, MA ;
Ellis, SM ;
Le Roux, CW ;
Withers, DJ ;
Frost, GS ;
Ghatei, MA ;
Bloom, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10) :941-948
[8]  
Beglinger Christoph, 2002, Curr Opin Investig Drugs, V3, P587
[9]   Behavior therapy and sibutramine for the treatment of adolescent obesity - A randomized controlled trial [J].
Berkowitz, RI ;
Wadden, TA ;
Tershakovec, AM ;
Cronquist, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (14) :1805-1812
[10]  
Black Shawn C, 2004, Curr Opin Investig Drugs, V5, P389